| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | ORN | United States | $9.05 | $852,260,000.00 | Strong Buy | 4 | 2007 |
#2 | EYE | United States | $16.69 | $1,987,488,000.00 | Strong Buy | 9 | 2017 |
#3 | CXDO | United States | $5.91 | $68,167,000.00 | Strong Buy | 5 | 1999 |
#4 | BXMT | United States | $13.81 | $0.00 | Buy | 5 | 1998 |
#5 | DRH | United States | $12.00 | $1,120,491,000.00 | Buy | 10 | 2004 |
#6 | SPIR | United States | $12.02 | $110,451,000.00 | Strong Buy | 5 | 2020 |
#7 | BANC | United States | $18.16 | $1,818,792,000.00 | Strong Buy | 9 | 2002 |
#8 | HLMN | United States | $7.32 | $1,552,224,000.00 | Strong Buy | 5 | 2020 |
#9 | RUN | United States | $8.38 | $858,578,000.00 | Buy | 20 | 2015 |
#10 | CPRI | United Kingdom | $12.79 | $3,474,000,000.00 | Buy | 13 | 2011 |
#11 | EQPT | United States | $16.85 | $4,379,000,000.00 | Buy | 9 | 2025 |
#12 | ADTN | United States | $7.47 | $1,083,807,000.00 | Strong Buy | 4 | 1996 |
#13 | AVNW | United States | $18.66 | $243,858,000.00 | Strong Buy | 4 | 2007 |
#14 | LUNR | United States | $14.66 | $210,059,000.00 | Buy | 10 | 2021 |
#15 | MPLT | United States | $13.31 | $0.00 | Strong Buy | 7 | 2025 |
#16 | CALY | United States | $15.53 | $2,060,100,000.00 | Buy | 4 | 1994 |
#17 | COMP | United States | $10.33 | $6,961,600,000.00 | Strong Buy | 10 | 2021 |
#18 | BIOA | United States | $9.52 | $8,995,000.00 | Strong Buy | 6 | 2024 |
#19 | ARRY | United States | $4.36 | $1,284,141,000.00 | Buy | 19 | 2020 |
#20 | BLZE | United States | $13.53 | $145,835,000.00 | Buy | 6 | 2021 |
#21 | MFA | United States | $8.68 | $0.00 | Buy | 6 | 1998 |
#22 | AGNC | United States | $10.62 | $0.00 | Buy | 13 | 2008 |
#23 | KRMD | United States | $3.30 | $41,127,366.00 | Strong Buy | 4 | 2019 |
#24 | STTK | United States | $6.87 | $1,000,000.00 | Buy | 7 | 2020 |
#25 | VLY | United States | $13.38 | $0.00 | Strong Buy | 13 | 1994 |
#26 | RLMD | United States | $4.46 | $13,070.00 | Strong Buy | 5 | 2012 |
#27 | MAMA | United States | $15.60 | $95,420,129.00 | Strong Buy | 5 | 2011 |
#28 | REAL | United States | $10.01 | $692,845,000.00 | Buy | 8 | 2019 |
#29 | INGN | United States | $5.33 | $348,668,000.00 | Strong Buy | 4 | 2013 |
#30 | SHLS | United States | $6.70 | $475,331,000.00 | Buy | 14 | 2020 |
#31 | EVLV | United States | $5.06 | $145,905,000.00 | Strong Buy | 4 | 2020 |
#32 | IRT | United States | $16.27 | $657,696,000.00 | Buy | 10 | 2009 |
#33 | KVUE | United States | $18.75 | $15,124,000,000.00 | Buy | 11 | 2023 |
#34 | IMUX | United States | $14.58 | $0.00 | Strong Buy | 6 | 2013 |
#35 | ERAS | United States | $16.76 | $0.00 | Strong Buy | 12 | 2021 |
#36 | TRVI | United States | $16.57 | $0.00 | Strong Buy | 11 | 2019 |
#37 | RLAY | United States | $18.49 | $15,355,000.00 | Strong Buy | 10 | 2020 |
#38 | AIRG | United States | $5.02 | $51,779,000.00 | Strong Buy | 4 | 2016 |
#39 | MRBK | United States | $19.07 | $6,316,000.00 | Strong Buy | 4 | 2018 |
#40 | RZLT | United States | $4.50 | $0.00 | Strong Buy | 6 | 2011 |
#41 | FNB | United States | $17.87 | $0.00 | Strong Buy | 5 | 2002 |
#42 | APYX | United States | $3.05 | $0.00 | Strong Buy | 4 | 1995 |
#43 | ZNTL | United States | $3.71 | $0.00 | Buy | 5 | 2020 |
#44 | NWBI | United States | $15.14 | $0.00 | Buy | 4 | 2009 |
#45 | HBAN | United States | $16.43 | $1,562,000,000.00 | Buy | 14 | 2010 |
#46 | AEVA | United States | $14.78 | $0.00 | Strong Buy | 4 | 2020 |
#47 | DBVT | France | $13.42 | $5,636,000.00 | Buy | 7 | 2014 |
#48 | BFLY | United States | $8.18 | $97,610,000.00 | Strong Buy | 4 | 2020 |
#49 | TSHA | United States | $5.70 | $9,773,000.00 | Strong Buy | 8 | 2020 |
#50 | LOCO | United States | $14.99 | $401,701,000.00 | Buy | 4 | 2014 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $20 to Buy (September 2, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.